These criteria include patient age, tumor size, histological grade as well as the presence or absence of lymph nodes and distant metastases, in addition to hormone receptor, estrogen (ER), progesterone (PR) and human epidermal growth factor receptor 2 (HER2) status [9]. The gene discussed is ERBB2; the disease is neoplasm.